| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.009 |